In OVCA tumor cell lines we also observed increased PRAME expression after DAC treatment, which slightly increased recognition and killing potential by HLA-A*02:01-restricted PRAME TCR-T cells (Supplementary Figure 9). This evidence concerns the gene HLA-A and neoplasm.